Skip to ContentSkip to Navigation
About us Faculty of Science and Engineering Our Research GRIP Pharmaceutical Technology and Biopharmacy Output


Requests for reprints can be addressed to:

Wouter Hinrichs


Bolhuis GK, Engelhart JJP, Eissens AC

Compaction Properties of Isomalt

Eur J Pharm Biopharm, 72, 621-625, 2009


Bolhuis GK, Rexwinkel EG, Zuurman K

Polyols as filler-binders for disintegrating tablets prepared by direct compaction

Drug Dev Ind Pharm, 35, 671-677, 2009


Heijerman H, Westerman E, Conway S, Touw D, Döring G, for the consensus working group 1

Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus

J Cystic Fibrosis, 8, 295-315, 2009


Laksmana FL, Hartman Kok PJ, Frijlink HW, Vromans H, Van der Voort Maarschalk K

Development and Application of a Process Window for Achieving High-Quality Coating in a Fluidized Bed Coating Process

AAPS PharmSciTech, 10, 732-742, 2009


Laksmana FL, Hartman Kok PJ, Vromans H, Van der Voort Maarschalk K

Predicting the diffusion coefficient of water vapor through glassy HPMC films at different environmental conditions using the free volume additivity approach

Eur J Pharm Sci, 37, 545-554, 2009


Laksmana FL, Van Vliet LJ, Hartman Kok PJ, Vromans H, Frijlink HW, Van der Voort Maarschalk K

Quantitative image analysis for evaluating the coating thickness and pore distribution in coated small particles

Pharm Res, 26, 965-976, 2009


Munnik P, de Boer AH, Wissink J, Hagedoorn P, Heskamp I, de Kruijf W, van Rijn CJ, Frijlink HW, Zanen P,

In Vivo Performance Testing of the Novel Medspray((R)) Wet Aerosol Inhaler

J Aerosol Med Pulm Drug Deliv, 22, 317-321, 2009


Rasyid HN, van der Mei HC, Frijlink HW, Soegijoko S, van Horn JR, Busscher HJ, Neut D

Concepts for increasing gentamicin release from handmade bone cement bead

Acta Orthop, 80, 508-513, 2009


Rottier BL, van Erp CJP, Sluyter TS, Heijerman HGM, Frijlink HW, de Boer AH

Changes in Performance of the Pari eFlow® Rapid and Pari LC Plus™ during 6 Months Use by CF Patients

J Aerosol Med Pulm Drug Deliv, 22, 263-269, 2009


Schellekens RCA, Olsder GG, Langenberg SMCH, Boer T, Woerdenbag HJ, Frijlink HW, Ko sterink JGW, Stellaard F

Proof-of-concept study on the suitability of 13C-urea as a marker substance for assessment of in vivo behaviour of oral colon-targeted dosage forms

Br J Pharmacol, 158, 532-540, 2009


Srinarong P, Faber JH, Visser MR, Hinrichs WLJ, Frijlink HW

Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants

Eur J Pharm Biopharm, 73, 154-161, 2009


Staniek A, Woerdenbag HJ, Kayser O

Taxomyces andreanae: a presumed paclitaxel producer demystified?

Planta Med, 75, 1561-1566, 2009


Tu HA, Woerdenbag HJ, Kane S, Riewpaiboon A, van Hulst M, Postma MJ

Economic evaluations of hepatitis B vaccination for developing countries

Expert Rev Vaccines, 8, 907-920, 2009


de Vries TW, Rottier BL. Gjaltema D, Hagedoorn P, Frijlink HW, de Boer AH

Comparative in vitro evaluation of four corticosteroi d metered dose inhalers Consistency of delivered dose and particle size distribution

Respir Med, 103, 1167-1173, 2009


de Waard H, Grasmeijer N, Hinrichs WLJ, Eissens AC, Pfaffenbach PP, and Frijlink HW

Preparation of drug nanocrystals by controlled crystallization: application of a 3-way nozzle to prevent premature crystallization for large scale production.

Eur J Pharm Sci, 38, 224-229, 2009


Zijlstra GS, Wolting J, Prop J, Petersen AH, Hinrichs WLJ, Uges DRA, Kerstjens HAM, van der Bij W, Frijlink HW

The efficacy of a new pulmonary cyclosporine A powder formulation in the prevention of transplant rejection in rats

J Heart Lung Transplant, 28, 486-492, 2009


Zijlstra GS, Ponsioen B, Hummel S, Sanders NN, Hinrichs WLJ, de Boer AH, Frijlink HW

Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation
Pharm Dev Techn, 14, 358-368, 2009

Laatst gewijzigd:22 november 2012 16:41